Optometrists in Ramona, CA Accepting Medicare

4 Optometrists found. Showing 1 - 4

Dr. Gary Bruce Myers, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1140 Main St Ste 207, Ramona, CA 92065 Phone: 760-789-1191    Fax: 760-789-1216

Dr. Susan Truong Cervantes, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1662 Main St Ste B, Ramona, CA 92065 Phone: 760-788-3622    Fax: 760-788-4781

Dr. Susan Darnell Homesley, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1516 Main St, Suite 102, Ramona, CA 92065 Phone: 760-789-0950    Fax: 760-789-6057

Ramona Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 1662 Main St Ste B, Ramona, CA 92065 Phone: 760-788-3622

News Archive

Researchers identify urinary markers that predict bone problems in hip replacement patients

In a study published in the Journal of Orthopedic Research, investigators have identified urinary markers that differentiate total hip replacement patients who eventually develop bone tissue destruction, or osteolysis, from patients who do not.

Fear mongering abounds in health debate

"What many people say they fear most from an overhaul of the health care system [is] the prospect of the federal government's limiting the medical care they receive," the New York Times reports. Policy experts say people are right to worry about health care costs, but this fear of rationing is unrealistic. "[T]here is nothing in the current proposals in Washington to suggest that the country is likely to embark on a system of medical rationing anytime soon," the Times reports.

Discoveries suggest that asbestos may be more widespread in Nevada, Arizona

In 2011, geologists at the University of Nevada, Las Vegas, began discovering asbestos where none should be - in granite rocks with a geologic history not previously known to produce asbestos.

Hope for vaccine against Chlamydia

"Now that we know how the body defends itself against the Chlamydia bacteria, we can develop a vaccine that optimises that defence. We have a basic understanding of how the vaccine could work, but some work remains to be done. We believe that it will take a few years before the vaccine becomes a reality," says researcher Ellen Marks, the author of the thesis.

Highland subsidiary begins enrolment in Phase III study of HLD-200 in pediatric ADHD patients

Highland Therapeutics Inc., an emerging pharmaceutical company, today announced that its wholly owned subsidiary has begun enrolment in a Phase III study of HLD-200, the Company's novel formulation of methylphenidate, in pediatric patients with Attention-Deficit Hyperactivity Disorder ("ADHD").

Read more Medical News

› Verified 7 days ago